No Picture
News

Ionis presents positive Phase 2 data from open label extension study of donidalorsen at 2022 ACAAI Annual Meeting

– Interim results show sustained reduction in hereditary angioedema attacks and no new safety signals in patients treated for one year CARLSBAD, Calif., Nov. 13, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today presented […]

No Picture
News

OncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination with Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatment

PENNINGTON, N.J. and SAN DIEGO, Nov. 11, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company developing intratumoral immunotherapies that stimulate the patient’s immune system to target cancer […]

No Picture
News

Manufacturing roundup: Alcami acquired by capital groups; Wheeler Bio starts on new manufacturing site in Oklahoma

Two investment groups have come together to purchase the CDMO Alcami. Global Healthcare Opportunities, otherwise known as GHO Capital, and The Vistra Group joined to acquire a controlling interest in the Alcami Corporation from funds […]

No Picture
News

Biological Dynamics, an early detection disease management company, expands leadership

Company prepares for commercialization, continued ExoVerita™ platform development and funding SAN DIEGO, Nov. 10, 2022 /PRNewswire/ — Biological Dynamics, an exosome isolation technology and early disease detection company, today announced new executive appointments to fuel […]

No Picture
News

Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK Cell Therapy Candidate, at SITC 2022 Annual Meeting

SAN DIEGO–(BUSINESS WIRE)– #SITC2022–Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK Cell Therapy Candidate, at SITC 2022 Annual Meeting Click here to view original post

No Picture
News

Element Introduces New Element LoopSeq™ Long-Read Sequencing Kits Designed for the AVITI™ System

Affordable, On Demand Access to High-Quality Long Reads on a Benchtop Sequencer SAN DIEGO, Nov. 10, 2022 /PRNewswire/ — Element Biosciences, Inc.— developer of an innovative DNA sequencing platform disrupting the genomics industry — today […]

No Picture
News

Preclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for Neuroscience

EVANSTON, Ill.–(BUSINESS WIRE)–Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced upcoming poster presentations at the 52nd Annual Meeting of the Society for […]

No Picture
News

Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 9, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its […]

No Picture
News

Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer

NEW YORK–(BUSINESS WIRE)– #CheckYourFoodTube–Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the commencement of production of […]

No Picture
News

Ionis reports third quarter financial results

Advanced key priorities: initiated manufacturing infrastructure project to support growth Increased 2022 cash and investments guidance CARLSBAD, Calif., Nov. 9, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the “Company”) today reported financial results for […]

No Picture
News

Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Highlights Recent Corporate Updates

– APONVIE™ approval by FDA, U.S. launch planned for Q1 2023 – – ZYNRELEF® unit demand grew 18% over prior quarter in Q3 2022 – – Oncology Care Franchise net product sales grew 13% over […]

No Picture
News

Leica Biosystems Acquires Cell IDx, Moving its Multiplexing Menu Forward with Ready-to-Use, Pre-Kitted Formulations

SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling. Founded in 2012 and […]

No Picture
News

OncoSec Announces Reverse Stock Split

PENNINGTON, N.J. and SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient’s own immune system […]

No Picture
News

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease

SAN DIEGO, Calif. and CALIFORNIA, Md., Nov. 8, 2022 /PRNewswire/ — Sentynl Therapeutics, Inc. (“Sentynl”) a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare disease, joins the global Menkes disease […]